Skip to main content
v2026.11,986 entries · CC-BY 4.0

Editorial · CASRAI · Funding lifecycle and financial vocabulary

Senate FY2027 health draft proposes $48.99 billion for NIH

The Senate health funding draft proposes $48.99 billion for NIH and would retain indirect cost protections for universities.

Published 17 Nov 2026· 5 minute read

Ask CASRAI · free to try

Ask about this story

2 free questions a day, no account.

An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.

CASRAI is the reference for research administration — bookmark it for the next question.

Senate Appropriations Chair Susan Collins released a fiscal year 2027 Labor-HHS-Education funding proposal in Washington on November 16, 2026, with a $48.99 billion program level for the National Institutes of Health. The draft gives universities a new negotiating benchmark for biomedical research funding and would retain restrictions on changes to NIH indirect cost policy.

A new health funding proposal enters the spending talks

Bloomberg Government reported on November 16 that Collins’s proposal would provide HHS with $112 billion in discretionary spending, almost $3 billion below its fiscal 2026 level. The department-wide reduction and the proposed NIH increase describe different parts of the health budget; the HHS headline alone does not describe the allocation for biomedical research.

The official bill text is labeled a committee print prepared for markup. Its number and report number are placeholders. Those features identify the document as draft legislation rather than an enacted appropriation or an NIH funding announcement. Researchers cannot treat its proposed allocations as money awarded to their institutions.

The NIH allocation and selected institute budgets

The accompanying explanatory statement sets out $47,562,518,000 in NIH base discretionary resources and $1,427,482,000 in Public Health Service Act section 241 transfers. Together they produce the stated $48.99 billion program level. The statement describes that as a $500 million increase from its fiscal 2026 enacted comparison. It says fiscal 2026 figures reflect Public Law 119–75, adjusted for comparability where noted.

The following selected institute appropriations appear in the draft bill. They are components of the proposal, rather than additional sums to add to the NIH headline total.

Institute Proposed FY2027 appropriation
National Cancer Institute $7,512,159,000
National Heart, Lung, and Blood Institute $3,990,345,000
National Institute of Allergy and Infectious Diseases $6,605,279,000
National Institute on Aging $4,567,623,000

Indirect costs and multiyear awards remain central

Section 224 would continue the NIH indirect cost provisions of 45 CFR Part 75 as applied in the third quarter of fiscal 2017, including restrictions on developing or implementing a modified approach. This is a proposed continuation of the framework relevant to universities’ negotiated NIH facilities and administrative costs.

Section 239 would cap fiscal 2027 obligations for more than one year of a multiyear award at the amount obligated for that purpose in fiscal 2025. Its definition covers grants, cooperative agreements, contracts and other financial mechanisms. The restriction concerns the amount committed across award years; it does not establish a grant success rate.

The explanatory statement expresses concern that funding all years of competing research project grants upfront would reduce the number NIH can support. It urges institutes receiving increases to use additional funds for new and competing research project grants.

Current grant operations still follow the continuing resolution

This health proposal follows the separate November 12 science spending drafts covered in CASRAI’s report on the NSF and NASA proposals. A new Senate health draft adds another negotiating position; it does not replace current operating instructions for NIH recipients.

NIH’s September 28 notice, NOT-OD-26-131, says the agency operates under a continuing resolution through December 11, 2026, at fiscal 2026 enacted levels. Institutes and centers may issue non-competing awards below the amounts indicated in the most recent Notice of Award. NIH says upward adjustments will be considered after fiscal 2027 appropriations are enacted and expects institutions to monitor expenditure carefully.

Universities had sought protection for grant administration

In its September 1 analysis of the funding negotiations, Harvard’s Office of Federal Relations described the House funding bills as a floor for negotiations with the Senate. It said the House drafts rejected the President’s deepest proposed cuts but still reduced support for many agencies and programs important to higher education.

Harvard also highlighted the continuing resolution’s temporary block on implementation of proposed Uniform Guidance changes, which would expand federal authority to terminate awards and introduce political considerations into grant decisions. Its analysis said research and higher education groups had engaged Congress on extending grant-policy protections through fiscal 2027. Those concerns predated the November 16 health draft.

What university research offices can take from the draft

For institutional planning, the useful distinction is between a proposed institute budget and an individual award decision. Neither an institute appropriation nor a proposed NIH increase establishes an NIH payline. A laboratory’s hiring or purchasing commitment should therefore follow its award documents and institutional approvals, rather than the proposed national total.

Research offices can use the draft when developing alternative research budget scenarios: one for current award support, and another for an eventual full-year settlement. The indirect cost provision and multiyear obligation limit warrant separate attention because they concern reimbursement and the distribution of funding across award years, respectively.

The next dated decision point is December 11

Bloomberg’s November 16 overview says Republican appropriators released additional full-year bills to spur negotiations, while a bipartisan agreement on the defense topline remained outstanding. December 11 is the deadline associated with the current government funding measure. The NIH proposal’s practical effect depends on the legislation that emerges from those negotiations and subsequent agency implementation.

Sources

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →